Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics

BURLINGAME, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) — Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agreement with Five Prime Therapeutics, Inc. (NASDAQ:FPRX). The non-exclusive license grants Five Prime rights to use the AlivaMab Mouse for antibody drug discovery and development. “Ablexis is … Continued

Read More

Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma

AlivaMab Mouse Emerging as Top Pharmas’ Next-Generation Antibody Drug Discovery Platform of Choice BURLINGAME, Calif.–(BUSINESS WIRE)– 2, 2016 – Ablexis, LLC announced today the expansion of the roster of licensees of its AlivaMab Mouse technology to include an additional top 15 pharmaceutical company. The AlivaMab Mouse is a unique, next-generation transgenic mouse platform for human … Continued

Read More

MariaDB selected as Database of the Year.

MariaDB has been selected as Database of the Year in the Members’ Choice awards at LinuxQuestions.org for the third year running. The LinuxQuestions.org forum is the largest Linux user forum online, hosting from 100,000 to a million visitors every month. In a resounding show of support, fans gave MariaDB 45.5% of the vote, more than … Continued

Read More

FDA Expands Label Indication for PleuraFlow to Reduce Retained Blood

FDA Expands Label Indication for PleuraFlow to Reduce Retained Blood | Business Wire ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that the United States Food & Drug Administration (FDA) has granted expanded Indications for Use of the company’s patented PleuraFlow® Active Clearance Technology® System. The PleuraFlow System is … Continued

Read More

ClearFlow’s PleuraFlow System Exhibited at Association of Physician Assistants in Cardiovascular Surgery Meeting

Anaheim, CA – March 2, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently exhibiting its innovative PleuraFlow® Active Clearance Technology® System at the 34th annual Association of Physician Assistants in Cardiovascular Surgery (APACVS) meeting in Las Vegas. PleuraFlow will also be displayed at the Maquet Medical Systems USA booth through March 4th. … Continued

Read More

OrthAlign, Inc. Receives CE Mark Approval for ORTHALIGN PLUS®, the most complete palm-sized positioning device for use in Total Hip Arthroplasty Surgery: Acetabular Cup Placement, Leg Length, and Joint Offset

Aliso Viejo, CA – February 3, 2015 – OrthAlign, Inc., a privately held medical device and technology company, received CE Mark Approval to market its OrthAlign Plus® system, a palm-sized, single-use positioning device for Total Hip (acetabular cup placement, leg length, and joint offset) and Total Knee (tibial and femoral) Arthroplasty surgeries, in Europe and … Continued

Read More

Education.com Names Former Adobe and Yahoo Executive Culligan to COO Post

New COO prepares early education leader for next phase of growth REDWOOD CITY, Calif., Jan. 29, 2015 — Surpassing 70 million visitors in 2014, Education.com has named Burke Culligan its Chief Operating Officer (COO). Culligan previously served in senior product management roles for Adobe Systems Digital Documents group and Yahoo’s Global HomePage group.  As Education.com’s COO, … Continued

Read More

Maquet Medical Systems USA Announces Exclusive US Distribution Agreement with ClearFlow for PleuraFlow® Active Clearance Technology® System

WAYNE, N.J., Jan. 23, 2015 /PRNewswire/ — Maquet Medical Systems USA announced today an exclusive US distribution agreement with ClearFlow, Inc. for its innovative PleuraFlow® Active Clearance Technology® (ACT™) System. The PleuraFlow System enables caregivers to actively keep chest drainage tubes clear of clot in the early hours after heart surgery. Maquet’s sales representatives in … Continued

Read More

Ablexis Announces Availability of the AlivaMab Mouse Technology and Settlement of the Litigation with Regeneron Pharmaceuticals, Inc.

Novel, Fully Validated Transgenic Mouse Platform for the Discovery of Antibody Therapeutics Delivered to Pfizer and Other Licensees Earlier in 2014 San Francisco – December 4, 2014 – Ablexis, LLC today announced the completion and delivery to its licensees of its AlivaMab Mouse technology, an innovative and unique platform for discovery of the next generation of breakthrough … Continued

Read More

California Technology Ventures Gets Exit from AngioScore

Pasadena-based venture capital firm California Technology Ventures has scored an exit at one of its portfolio firms, selling cardiac catheter maker AngioScore, to medical device firm Spectranetics. Spectranetics said it would pay $230M plus earnout for AngioScore, which was backed by California Technology Ventures, Innomed Ventures, Linkagene LP, Pelion Ventures, Psilos Group Management, QuestMark Partners, … Continued

Read More